Patents by Inventor Robert G. Bell

Robert G. Bell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intranasal epinephrine formulations and methods for the treatment of disease
    Patent number: 11918655
    Abstract: Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.
    Type: Grant
    Filed: June 7, 2023
    Date of Patent: March 5, 2024
    Assignee: AEGIS THERAPEUTICS, LLC
    Inventors: Richard Lowenthal, Edward T. Maggio, Robert G. Bell, Pratik Shah
  • INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE
    Publication number: 20240024485
    Abstract: Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.
    Type: Application
    Filed: June 7, 2023
    Publication date: January 25, 2024
    Inventors: Richard LOWENTHAL, Edward T. MAGGIO, Robert G. BELL, Pratik SHAH
  • INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE
    Publication number: 20230302137
    Abstract: Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.
    Type: Application
    Filed: June 1, 2023
    Publication date: September 28, 2023
    Inventors: Richard LOWENTHAL, Edward T. MAGGIO, Robert G. BELL, Pratik SHAH
  • Intranasal epinephrine formulations and methods for the treatment of disease
    Patent number: 11744895
    Abstract: Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.
    Type: Grant
    Filed: August 6, 2021
    Date of Patent: September 5, 2023
    Assignee: AEGIS THERAPEUTICS, LLC
    Inventors: Richard Lowenthal, Edward T. Maggio, Robert G. Bell, Pratik Shah
  • Intranasal epinephrine formulations and methods for the treatment of disease
    Patent number: 11717571
    Abstract: Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.
    Type: Grant
    Filed: October 26, 2022
    Date of Patent: August 8, 2023
    Assignee: AEGIS THERAPEUTICS, LLC
    Inventors: Richard Lowenthal, Edward T. Maggio, Robert G. Bell, Pratik Shah
  • INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE
    Publication number: 20230085636
    Abstract: Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.
    Type: Application
    Filed: October 26, 2022
    Publication date: March 23, 2023
    Inventors: Richard LOWENTHAL, Edward T. MAGGIO, Robert G. BELL, Pratik SHAH
  • Intranasal epinephrine formulations and methods for the treatment of disease
    Patent number: 11191838
    Abstract: Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.
    Type: Grant
    Filed: May 7, 2020
    Date of Patent: December 7, 2021
    Assignee: AEGIS THERAPEUTICS, LLC
    Inventors: Richard Lowenthal, Edward T. Maggio, Robert G. Bell, Pratik Shah
  • INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE
    Publication number: 20210361770
    Abstract: Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.
    Type: Application
    Filed: August 6, 2021
    Publication date: November 25, 2021
    Inventors: Richard LOWENTHAL, Edward T. MAGGIO, Robert G. BELL, Pratik SHAH
  • INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE
    Publication number: 20200261582
    Abstract: Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.
    Type: Application
    Filed: May 7, 2020
    Publication date: August 20, 2020
    Inventors: Richard LOWENTHAL, Edward T. MAGGIO, Robert G. BELL, Pratik SHAH
  • Intranasal epinephrine formulations and methods for the treatment of disease
    Patent number: 10682414
    Abstract: Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.
    Type: Grant
    Filed: May 22, 2019
    Date of Patent: June 16, 2020
    Assignee: AEGIS THERAPEUTICS, LLC
    Inventors: Richard Lowenthal, Edward T. Maggio, Robert G. Bell, Pratik Shah
  • INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE
    Publication number: 20190269780
    Abstract: Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.
    Type: Application
    Filed: May 22, 2019
    Publication date: September 5, 2019
    Inventors: Richard LOWENTHAL, Edward T. MAGGIO, Robert G. BELL, Pratik SHAH
  • INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE
    Publication number: 20190269782
    Abstract: Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.
    Type: Application
    Filed: May 22, 2019
    Publication date: September 5, 2019
    Inventors: Richard LOWENTHAL, Edward T. MAGGIO, Robert G. BELL, Pratik SHAH
  • INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE
    Publication number: 20190269781
    Abstract: Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.
    Type: Application
    Filed: May 22, 2019
    Publication date: September 5, 2019
    Inventors: Richard LOWENTHAL, Edward T. MAGGIO, Robert G. BELL, Pratik SHAH
  • Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
    Patent number: 8680084
    Abstract: This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several combination oral contraceptive regimens in combination with an antidepressant and a kit containing the same.
    Type: Grant
    Filed: August 30, 2012
    Date of Patent: March 25, 2014
    Assignee: Teva Women's Health, Inc.
    Inventors: Robert G. Bell, Carole Ben-Maimon, Beata Iskold
  • Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
    Patent number: 8338396
    Abstract: This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several combination oral contraceptive regimens in combination with an antidepressant and a kit containing the same.
    Type: Grant
    Filed: May 24, 2010
    Date of Patent: December 25, 2012
    Assignee: Teva Women's Health, Inc.
    Inventors: Robert G. Bell, Carole Ben-Maimon, Beata Iskold
  • Oral Contraceptives to Prevent Pregnancy and Diminish Premenstrual Symptomatology
    Publication number: 20120322777
    Abstract: This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several combination oral contraceptive regimens in combination with an antidepressant and a kit containing the same.
    Type: Application
    Filed: August 30, 2012
    Publication date: December 20, 2012
    Inventors: Robert G. Bell, Carole Ben-Maimon, Beata Iskold
  • METHODS OF HORMONAL TREATMENT UTILIZING CONTRACEPTIVE REGIMENS WITH CONTINUOUS ESTROGEN ADMINISTRATION
    Publication number: 20110124611
    Abstract: The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The disclosed contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
    Type: Application
    Filed: October 26, 2010
    Publication date: May 26, 2011
    Applicant: TEVA WOMEN'S HEALTH, INC.
    Inventors: ROBERT G. BELL, CAROLE S. BEN-MAIMON, BEATA ISKOLD, LANCE J. BRONNENKANT, HOWARD HAIT, KATHLEEN Z. REAPE
  • Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
    Patent number: 7858605
    Abstract: This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several combination oral contraceptive regimens in combination with an antidepressant and a kit containing the same.
    Type: Grant
    Filed: December 6, 2007
    Date of Patent: December 28, 2010
    Assignee: Teva Women's Health, Inc.
    Inventors: Robert G. Bell, Carole Ben-Maimon, Beata Iskold
  • Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
    Patent number: 7855190
    Abstract: The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The disclosed contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
    Type: Grant
    Filed: July 16, 2004
    Date of Patent: December 21, 2010
    Assignee: Teva Women's Health, Inc.
    Inventors: Robert G. Bell, Carole S. Ben-Maimon, Beata Iskold, Lance J. Bronnenkant, Howard Hait, Kathleen Z. Reape
  • Oral Contraceptives to Prevent Pregnancy and Diminish Premenstrual Symptomatology
    Publication number: 20100298279
    Abstract: This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several combination oral contraceptive regimens in combination with an antidepressant and a kit containing the same.
    Type: Application
    Filed: May 24, 2010
    Publication date: November 25, 2010
    Inventors: Robert G. BELL, Carole BEN-MAIMON, Beata ISKOLD